In last trading session, Predictive Oncology Inc (NASDAQ:POAI) saw 0.74 million shares changing hands with its beta currently measuring 1.16. Company’s recent per share price level of $1.36 trading at $0.02 or 1.49% at ring of the bell on the day assigns it a market valuation of $9.06M. That closing price of POAI’s stock is at a discount of -176.47% from its 52-week high price of $3.76 and is indicating a premium of 59.56% from its 52-week low price of $0.55. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.37 million shares which gives us an average trading volume of 1.10 million if we extend that period to 3-months.
For Predictive Oncology Inc (POAI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Predictive Oncology Inc (NASDAQ:POAI) trade information
Upright in the green during last session for gaining 1.49%, in the last five days POAI remained trading in the green while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $1.36 price level, adding 55.56% to its value on the day. Predictive Oncology Inc’s shares saw a change of 65.85% in year-to-date performance and have moved 47.83% in past 5-day. Predictive Oncology Inc (NASDAQ:POAI) showed a performance of 69.98% in past 30-days. Number of shares sold short was 0.15 million shares which calculate 1.26 days to cover the short interests.
Predictive Oncology Inc (POAI) estimates and forecasts
Statistics highlight that Predictive Oncology Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 34.65% of value to its shares in past 6 months, showing an annual growth rate of 40.23% while that of industry is 24.90. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 350k for the same. And 1 analysts are in estimates of company making revenue of 1.5M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 53.33% during past 5 years.
Predictive Oncology Inc (NASDAQ:POAI)’s Major holders
Insiders are in possession of 2.16% of company’s total shares while institution are holding 4.01 percent of that, with stock having share float percentage of 4.10%. Investors also watch the number of corporate investors in a company very closely, which is 4.01% institutions for Predictive Oncology Inc that are currently holding shares of the company. ADVISORNET FINANCIAL, INC is the top institutional holder at POAI for having 95.0 shares of worth $99.0. And as of 2024-06-30, it was holding 0.0023 of the company’s outstanding shares.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 69.88 shares of worth $95038.0 or 1.05% of the total outstanding shares. The later fund manager was in possession of 34.66 shares on Nov 30, 2024 , making its stake of worth around $47144.0 in the company or a holder of 0.52% of company’s stock.
